| Life Care Center Of Andover | |
| 621 W 21st, Po Box 100, Andover, Kansas 67002 | |
| (316) 733-1349 | |
| Name | Life Care Center Of Andover |
|---|---|
| Location | 621 W 21st, Po Box 100, Andover, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 154 |
| Occupancy Rate | 46.04% |
| Medicare ID (CCN) | 175157 |
| Legal Business Name | Andover Medical Investors, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1194771410 |
| Organization Name | ANDOVER MEDICAL INVESTORS, LLC |
| Doing Business As | LIFE CARE CENTER OF ANDOVER |
| Address | 621 W 21st St, Andover, KS 67002 |
| Phone Number | 316-733-1349 |
News Archive
Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Diabetes patients have an increased risk of suffering serious infections or death compared to the general public, new research has shown.
The 20th century was dominated by breakthroughs in physics and chemistry, but the 21st century will belong to genetics and biotechnology. Cancer research is just one area among many that is being transformed by the sequencing of the human genome. This was one of the topics discussed in our recent panel with leading cancer researchers, part of our Breakthroughs: Cancer series.
Children who are exposed in utero to high levels of particulate air pollution during the second trimester of pregnancy may be at greater risk of developing asthma in early childhood, according to a new study presented at the 2014 American Thoracic Society International Conference.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Diabetes patients have an increased risk of suffering serious infections or death compared to the general public, new research has shown.
The 20th century was dominated by breakthroughs in physics and chemistry, but the 21st century will belong to genetics and biotechnology. Cancer research is just one area among many that is being transformed by the sequencing of the human genome. This was one of the topics discussed in our recent panel with leading cancer researchers, part of our Breakthroughs: Cancer series.
Children who are exposed in utero to high levels of particulate air pollution during the second trimester of pregnancy may be at greater risk of developing asthma in early childhood, according to a new study presented at the 2014 American Thoracic Society International Conference.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 5 |
| Total Amount of Fines in Dollars | $350463 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 6 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.43 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 45.06 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.71 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.37 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.5 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.24 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.94 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.78 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.75 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.57 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.55 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.27 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.72 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 64.45 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 75.11 | 82.93 |
News Archive
Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Diabetes patients have an increased risk of suffering serious infections or death compared to the general public, new research has shown.
The 20th century was dominated by breakthroughs in physics and chemistry, but the 21st century will belong to genetics and biotechnology. Cancer research is just one area among many that is being transformed by the sequencing of the human genome. This was one of the topics discussed in our recent panel with leading cancer researchers, part of our Breakthroughs: Cancer series.
Children who are exposed in utero to high levels of particulate air pollution during the second trimester of pregnancy may be at greater risk of developing asthma in early childhood, according to a new study presented at the 2014 American Thoracic Society International Conference.
› Verified 2 days ago
Life Care Center Of Andover Location: 621 W 21st, Po Box 100, Andover, Kansas 67002 Phone: (316) 733-1349 | |